Decibel Cannabis Company (DB) investor relations material

Company overview and market position

• Sixth largest Canadian cannabis company with nationwide presence and leading brands, including a top-three brand in Canada.

• Recent acquisition is fueling growth and enabling entry into international markets.

• Management team has been consistent since inception, maintaining profitability and revenue growth in a challenging sector.

• Domestic sales currently represent 85% of total sales, with international at 15%.

• Focus on value-added products like pre-rolls and vapes, which differentiate from traditional flower products.

Industry trends and international expansion

• Global cannabis industry is growing at a 25% CAGR, with Canada outpacing global growth through exports.

• Canadian market is mature, growing at 5% annually, while international markets like Germany and Australia are expanding rapidly.

• Germany is leading European growth, with other EU countries expected to follow.

• International markets are currently medical-focused, with flower as the main product, but value-added products are expected to gain traction.

• Company operates in seven countries and is positioned to expand as more markets legalize.

Operational strengths and competitive advantages

• Canadian experience has driven lean operations, margin focus, and product innovation.

• Facilities are highly scalable and licensed for both domestic and international production.

• Holds one of 13 licenses for flower exports and one of three for extract exports, providing a unique market position.

• Internal production is sold out, with throughput capacity expected to reach 60 tons by year-end.

• Can facilitate exports for other producers, charging processing fees and leveraging regulatory compliance.